Trial intelligence / Profile preview

Atorvastatin in Traumatic Brain Injury

NCT04718155Completed

Sponsor
Assiut University
Start
Mar 2021
Primary completion
Apr 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of atorvastatin in traumatic brain injury (TBI) (2 arms), sponsored by Assiut University. Primary endpoint: Brain Magnetic Resonance Spectroscopy at 48 hours. Started Mar 2021; status: completed.

02

Drugs

atorvastatin
03

Conditions

traumatic brain injury (TBI)

Beyond the preview

Go deeper on NCT04718155.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04718155.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call